SOD1 and amyotrophic lateral sclerosis: In this study, we demonstrate the up-regulation of miR-133a serum levels in ALS mice independently from disease velocity; these results are in sharp contrast with our previous analysis of miR-133a in serum samples of ALS patients [11] and with data obtained in denervated and re-innervating wild type mice, both of which exhibit low serum levels of miR-133a throughout the disease, suggesting that circulating levels of miR-133a are strictly correlated to the expression of the SOD1 mutant gene rather than to motor neuron degeneration and ALS disease.